
Currently out of the existing stock ratings of David Dai, 65 are a BUY (79.27%), 17 are a HOLD (20.73%).
Analyst David Dai, currently employed at UBS, has had 44.55% of price targets met with an average potential upside of 15.86%, reached in 91 days on average. Previously, David Dai worked at BERNSTEIN.
David Dai has documented 167 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical, Communication Services sectors.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 03-Nov-2026.
Analyst best performing recommendations are on ARM (ARM HOLDINGS PLC).
The best stock recommendation documented was for ARM (ARM HOLDINGS PLC) on 5/18/2026. The price target of $300 was fulfilled within 4 days with a profit of $84.88 (39.46%), with a performance score of 98.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Jul-2024
1 years 2 months 28 days ago
(22-Aug-2025)
6/6 (100%)
$27 (0.00%)
1120
Buy Since 09-Aug-2022
$46
$48
3 years 8 months 12 days ago
(07-Mar-2023)
6/6 (100%)
$46 (0.00%)
1384
Buy Since 23-Aug-2022
$45
$30
4 years 2 months 27 days ago
(23-Aug-2022)
2/2 (100%)
$45 (0.00%)
1498
Buy
$40
4 years 8 months 3 days ago
(16-Mar-2022)
0/1 (0%)
$17.23 (75.67%)
$60
$30
5 years 1 months 7 days ago
(12-Oct-2021)
2/2 (100%)
$60 (0.00%)
1658
Which stock is David Dai most bullish on?
Which stock is David Dai most reserved on?
What Year was the first public recommendation made by David Dai?